Dow Up 0.75% Nasdaq Up 1.03%

Achillion Pharmaceuticals, Inc. (ACHN)

-NMS
11.23 Up 0.17(1.54%) 9:31AM EDT - Nasdaq Real Time Price
Prev Close:11.06
Open:N/A
Bid:11.21 x 100
Ask:11.35 x 400
1y Target Est:13.67
Beta:2.34
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:11.18 - 11.34
52wk Range:2.26 - 13.80
Volume:78,185
Avg Vol (3m):6,034,870
Market Cap:1.10B
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACHNUp 1.54%1.10B
GSKUp 1.61%108.39B
JNJUp 1.04%288.43B
RHHBY 0.00%247.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-3.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback